Cargando…
Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19)
OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antim...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587378/ https://www.ncbi.nlm.nih.gov/pubmed/37184033 http://dx.doi.org/10.1017/ice.2023.27 |
_version_ | 1785123348778319872 |
---|---|
author | Park, Hiromichi S. McCracken, Caitlin M. Lininger, Noah Varley, Cara D. Sikka, Monica K. Evans, Christopher Villamagna, Angela Holly Makadia, Jina T. McGregor, Jessina C. |
author_facet | Park, Hiromichi S. McCracken, Caitlin M. Lininger, Noah Varley, Cara D. Sikka, Monica K. Evans, Christopher Villamagna, Angela Holly Makadia, Jina T. McGregor, Jessina C. |
author_sort | Park, Hiromichi S. |
collection | PubMed |
description | OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antimicrobial therapy. DESIGN: Single-center retrospective cohort study of symptomatic inpatients admitted for COVID-19 from April 15, 2020, through June 30, 2021. SETTING: Academic quaternary-care referral center in Portland, Oregon. PATIENTS: The study included patients who were 18 years or older with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) PCR test up to 10 days prior to admission. METHODS: Secondary infections were identified based on clinical, radiographic, and microbiologic data. Logistic regression was used to identify risk factors for secondary infection. We also assessed mortality, length of stay, and empiric antibiotics among those with and without secondary infections. RESULTS: We identified 118 patients for inclusion; 31 (26.3%) had either culture-proven or possible secondary infections among hospitalized patients with COVID-19. Mortality was higher among patients with secondary infections (35.5%) compared to those without secondary infection (4.6%). Empiric antibiotic use on admission was high in both the secondary and no secondary infection groups at 71.0% and 48.3%, respectively. CONCLUSIONS: The incidence of secondary bacterial infection was moderate among hospitalized patients with COVID-19. However, a higher proportion of patients received empiric antibiotics regardless of an identifiable secondary infection. Transfer from an outside hospital, baseline immunosuppressant use, and corticosteroid treatment were independent risk factors for secondary infection. Additional studies are needed to validate risk factors and best guide antimicrobial stewardship efforts. |
format | Online Article Text |
id | pubmed-10587378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105873782023-10-21 Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) Park, Hiromichi S. McCracken, Caitlin M. Lininger, Noah Varley, Cara D. Sikka, Monica K. Evans, Christopher Villamagna, Angela Holly Makadia, Jina T. McGregor, Jessina C. Infect Control Hosp Epidemiol Original Article OBJECTIVE: The true incidence and risk factors for secondary bacterial infections in coronavirus disease 2019 (COVID-19) remains poorly understood. Knowledge of risk factors for secondary infections in hospitalized patients with COVID-19 is necessary to optimally guide selective use of empiric antimicrobial therapy. DESIGN: Single-center retrospective cohort study of symptomatic inpatients admitted for COVID-19 from April 15, 2020, through June 30, 2021. SETTING: Academic quaternary-care referral center in Portland, Oregon. PATIENTS: The study included patients who were 18 years or older with a positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) PCR test up to 10 days prior to admission. METHODS: Secondary infections were identified based on clinical, radiographic, and microbiologic data. Logistic regression was used to identify risk factors for secondary infection. We also assessed mortality, length of stay, and empiric antibiotics among those with and without secondary infections. RESULTS: We identified 118 patients for inclusion; 31 (26.3%) had either culture-proven or possible secondary infections among hospitalized patients with COVID-19. Mortality was higher among patients with secondary infections (35.5%) compared to those without secondary infection (4.6%). Empiric antibiotic use on admission was high in both the secondary and no secondary infection groups at 71.0% and 48.3%, respectively. CONCLUSIONS: The incidence of secondary bacterial infection was moderate among hospitalized patients with COVID-19. However, a higher proportion of patients received empiric antibiotics regardless of an identifiable secondary infection. Transfer from an outside hospital, baseline immunosuppressant use, and corticosteroid treatment were independent risk factors for secondary infection. Additional studies are needed to validate risk factors and best guide antimicrobial stewardship efforts. Cambridge University Press 2023-10 2023-05-15 /pmc/articles/PMC10587378/ /pubmed/37184033 http://dx.doi.org/10.1017/ice.2023.27 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Original Article Park, Hiromichi S. McCracken, Caitlin M. Lininger, Noah Varley, Cara D. Sikka, Monica K. Evans, Christopher Villamagna, Angela Holly Makadia, Jina T. McGregor, Jessina C. Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title_full | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title_fullStr | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title_full_unstemmed | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title_short | Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19) |
title_sort | incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (covid-19) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587378/ https://www.ncbi.nlm.nih.gov/pubmed/37184033 http://dx.doi.org/10.1017/ice.2023.27 |
work_keys_str_mv | AT parkhiromichis incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT mccrackencaitlinm incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT liningernoah incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT varleycarad incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT sikkamonicak incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT evanschristopher incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT villamagnaangelaholly incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT makadiajinat incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 AT mcgregorjessinac incidenceandriskfactorsforclinicallyconfirmedsecondarybacterialinfectionsinpatientshospitalizedforcoronavirusdisease2019covid19 |